101 results
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Chronic Kidney Disease ... Acute Kidney Diseases ... months No Kidney Disease ... per 1.73 m2 • Stable ... #Definitions #nephrology
Algorithm for the Treatment of Parkinson Disease With Predominant Postural Instability and Gait Impairment

#Management #Neurology #Parkinsons
Algorithm for the Treatment ... of Parkinson Disease ... #Management #Neurology ... #Parkinsons #Disease ... #Medication #Treatment
Common Biliary Diseases seen in the Emergency Room - Comparison Table:

Clinical Features, Labs, Imaging and Treatment

#Diagnosis
Common Biliary Diseases ... Room - Comparison Table ... Labs, Imaging and Treatment ... BiliaryDiseases #Table
Pharmacokinetics of commonly used diuretics medications in CKD, Cirrhotic Ascites, and Heart Failure
 • Furosemide
 •
Spironolactone MCW ... Nephrology @MCW_Nephrology ... halflife #comparison #table
Effects of Strokes by Location - Anterior vs Posterior Localization

Anterior Circulation 
 - MCA 
 -
Circulation - MCA ... Localization #Effects #Neurology ... #Diagnosis #Table ... Review in Clinical Neurology
Inherited Defects in Kidney Tubule Epithelial Cells

Renal glucosuria - Na+-dependent glucose cotransporter
Cystinuria - Amino acid transporter
Bartter
syndrome - Na-K-2Cl ... barrtin (recruits Cl ... Thiazide-sensitive Na—Cl ... Defects #Kidney #Nephrology ... #Differential #Table
Autoantibodies and their Disease Associations
ANA - Non-specific; common in SLE, autoimmune hepatitis
Anti-CCP, Rheumatoid factor - RA
Anti-dsDNA
Autoantibodies and their Disease ... syndrome Anti-Scl ... (TTG) - Celiac disease ... #Associations #diseases ... #diagnosis #table
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the Treatment ... Nonpharmacologic Treatments ... Pharmacologic Treatments ... nalfurafine 2.5 mcg ... #management #nephrology
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
interstitial lung disease ... >10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... optimization of GERD treatment
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Chronic Kidney Disease ... VisualAbstract #Nephrology